Immune Systems Advisor

A new protocol for patients suffering from Influenza and Respiratory Syncytial Virus (RSV) has been developed in a collaboration led by Dr Paul Marik, Dr Pierre Kory and the Front Line COVID-19 Critical Care Alliance (FLCCC). In adult patients, COVID-19 (Omicron variant), influenza, and RSV present with a similar constellation of symptoms and physical findings. It may therefore be difficult to distinguish between these infections (particularly COVID-19 and influenza) based on clinical presentation alone. For advice on how to protect yourself against infection, see I-PREVENT: COVID Protection Protocol . For treatment of COVID-19, see I-CARE: Early COVID Treatment Protocol . The Problem With the Tripledemic Narrative In a November 18, 2022, Science magazine article , Jon Cohen explained why a simultaneous tripledemic is unlikely: “Triple threat. Tripledemic. A viral perfect storm. These frightening phrases have dominated recent headlines as some health officials, clinicians...

As reported in this short news clip in 2021, research evidence  shows that probiotics may help reduce long-haul symptoms after COVID-19. Some people experience symptoms for weeks or months after a COVID-19 infection has resolved. When these symptoms persist for four weeks or more, they are known as long COVID, long-haul COVID, chronic COVID or long-haul syndrome.   In another  study published in 2021 , oral probiotic  strain, Streptococcus salivarius K12, clinically demonstrates protection against bacterial infections of the respiratory tract caused by  COVID-19  and other respiratory  viruses  making it a new weapon in the fight against infectious disease and COVID-19. The oral probiotic strain Streptococcus salivarius K12 works by crowding out bad bacteria and stopping its ability to colonize. New studies have also found that it has antibacterial and antiviral properties and stimulates inhibitory substances that k...